πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors β€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β€” searchable for business development and competitive intelligence.

359 results for β€œvaccine” Clear

  1. Trivalent live attenuated seasonal influenza vaccine

    The University of Hong Kong

    Influenza Virus Infection

    approved mab completed

    1 trial

  2. Two doses of inactivated SARS-CoV-2 vaccine at the schedule of day 0,28 and one dose Quadrivalent Influenza Vaccine on day 0 or day 28.

    Sinovac Research and Development Co.,

    COVID-19

    approved mab completed

    1 trial

  3. Two doses of quadrivalent influenza vaccine

    Sinovac Research and Development Co.,

    Seasonal Influenza

    approved mab completed

    1 trial

  4. Typhoid Vi vaccine

    International Peace Maternity and Child Health Hospital

    Typhoid

    approved mab completed

    1 trial

  5. Vaicella Vaccine+DTaP on Day 0, MMR on Day 30

    Sinovac Research and Development Co.,

    Varicella (chickenpox)

    approved mab active

    1 trial

  6. Varicella vaccine

    Sinovac Research and Development Co.,

    VZV

    approved mab completed

    1 trial

  7. Varicella vaccine+TIV

    Sinovac Research and Development Co.,

    Varicella

    approved mab completed

    1 trial

  8. Vaxigrip Tetra, suspensie voor injectie in een voorgevulde spuit Quadrivalent griepvaccin (gesplitst virion, geΓ―nactiveerd), Fluenz Tetra nasal spray suspension Influenza vaccine (live attenuated, nasal)

    Disc Medicine

    healthy individuals

    approved small molecule active

    1 trial

  9. hepatitis B vaccine made by Recombinant DNA Techniques in Saccharomyces Cerevisiae

    BRIGHT MINDS BIOSCIENCES INC.

    Hepatitis B Vaccines

    approved mab completed

    1 trial

  10. inactivated EV71 vaccine (KMB-17 cells)

    Chinese University of Hong Kong

    Hand, Foot and Mouth Disease (HFMD)

    approved mab completed

    1 trial

  11. sIPV vaccine /DTaP vaccine

    Sinovac Research and Development Co.,

    Poliomyelitis

    approved mab completed

    1 trial

  12. sIPV+DTaP+MMR

    BRIGHT MINDS BIOSCIENCES INC.

    Vaccine

    approved mab active

    1 trial

  13. seasonal split influenza vaccine

    Sinovac Research and Development Co.,

    Influenza

    approved mab completed

    1 trial

  14. split-virion, adjuvanted H1N1 vaccine of 7.5 ΞΌg per dose

    Sinovac Research and Development Co.,

    Influenza

    approved mab completed

    1 trial

  15. trivalent seasonal influenza vaccine

    Sinovac Research and Development Co.,

    Influenza

    approved mab completed

    1 trial

  16. Inactivated influenza vaccine

    The University of Hong Kong

    Influenza Virus Infection

    mab completed

    1 trial

  17. Personalized mRNA Tumor Vaccine

    The First People's Hospital of Lianyungang

    Esophageal Cancer

    mab active

    1 trial

  18. Recombinant COVID-19 Vaccine (Sf9 Cell)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    COVID-19

    mab completed

    1 trial

  19. SARS-CoV-2 Variant (Omicron BA.5) mRNA vaccine

    The First People's Hospital of Lianyungang

    SARS-CoV-2

    mab active

    1 trial

  20. SARS-CoV-2 mRNA Vaccine, Bivalent Low dose

    The First People's Hospital of Lianyungang

    SARS-CoV-2

    mab active

    1 trial

  21. Study subjects will be vaccinated with 3 (three) vaccine doses. The first vaccine will be administered intramuscularly starting at 6-12 weeks of age followed by two doses at four-week interval

    Biotech Pharmaceutical Co.,

    Diphtheria

    mab completed

    1 trial

  22. TIV 2010/2011 influenza vaccine

    The University of Hong Kong

    Influenza

    mab completed

    1 trial

  23. seasonal influenza vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Influenza, Human

    mab completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources